Veracyte traded at $26.42 this Wednesday November 23rd, increasing $0.05 or 0.19 percent since the previous trading session. Looking back, over the last four weeks, Veracyte gained 64.51 percent. Over the last 12 months, its price fell by 37.41 percent. Looking ahead, we forecast Veracyte to be priced at 25.13 by the end of this quarter and at 22.73 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Agilent 155.35 -1.51 -0.96% 1.56%
Agenus 3.00 -0.04 -1.32% -10.18%
Anika Therapeutics 30.45 -0.34 -1.10% -24.94%
Arrowhead Research 29.40 -0.15 -0.51% -60.29%
Biocept 0.78 -0.01 -0.87% -78.95%
Bruker 68.44 0.13 0.19% -11.46%
Exact Sciences 43.09 0.86 2.04% -51.08%
Heron Therapeutics 2.88 -0.01 -0.35% -70.52%
Illumina 222.08 -0.09 -0.04% -39.25%
Immunogen 5.16 -0.13 -2.46% 4.88%
Karyopharm Therapeutics 4.91 0.09 1.87% -36.23%
Ligand Pharmaceuticals 73.14 -1.73 -2.31% -54.68%
Laboratory Of America 238.29 1.54 0.65% -16.02%
Myriad Genetics 19.45 -0.31 -1.57% -29.20%
Rigel Pharmaceuticals 0.76 -0.02 -2.13% -74.01%
Roche Holding 310.95 2.40 0.78% -14.11%
Sangamo BioSciences 3.55 -0.05 -1.39% -60.29%
Sonic Healthcare 32.01 0.24 0.76% -23.05%
Siemens 130.52 -0.44 -0.34% -10.13%
Thermo Fisher Scientific 547.29 2.54 0.47% -14.32%
Veracyte 26.42 0.05 0.19% -37.41%
Waters 334.57 -2.40 -0.71% -2.70%
Intrexon 2.02 0.08 4.12% -50.12%

Indexes Price Day Year
USND 11285 110.91 0.99% -28.78%
US2000 1864 3.08 0.17% -20.07%

Veracyte
Veracyte, Inc. is a genomic diagnostics company. The Company, through its scientific platform, which utilizes ribonucleic acid (RNA), whole-transcriptome sequencing combined with machine learning, produces genomic tests. It provides various genomic tests, including Afirma Genomic Sequencing Classifier (GSC), Percepta Bronchial Genomic Classifier, Envisia Genomic Classifier and Afirma Xpression Atlas. It provides GSC tests for thyroid cancer. It provides Percepta Bronchial Genomic Classifier tests for lung cancer. It provides Envisia Genomic Classifier tests for idiopathic pulmonary fibrosis (IPF). Its Afirma Xpression Atlas provides information on gene alterations associated with thyroid cancer, enabling physicians to tailor surgical and treatment decisions at time of diagnosis.